ARQT - Company ID 0001787306
The table below shows Arcutis Biotherapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $34.76M | $47.12M | $72.74M | $53.10M | $134.85M | $84.27M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $144.38M | $115.12M | $106.69M | $85.42M | $60.12M | $43.41M |
| Inventory | $37.39M | $22.42M | $16.32M | $16.61M | $14.02M | $13.88M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $438.06M |
| $349.22M |
| $332.78M |
| $323.67M |
| $423.72M |
| $434.59M |
| Property, plant & equipment | $1.04M | $1.22M | $1.39M | $1.50M | $1.19M | $1.35M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $460.00M | $370.98M | $352.43M | $344.11M | $437.35M | $444.76M |
| Accounts payable | $18.30M | $5.79M | $15.08M | $24.53M | $19.32M | $7.94M |
| Total current liabilities | $163.20M | $99.77M | $103.94M | $91.13M | $172.43M | $51.35M |
| Long-term debt | $101.47M | $107.50M | $107.05M | $107.62M | $105.09M | $203.81M |
| Total liabilities | $270.36M | $212.90M | $213.46M | $201.45M | $280.71M | $258.33M |
| Retained earnings | -$1.15B | -$1.16B | -$1.16B | -$1.15B | -$1.11B | -$1.07B |
| Total equity | $189.65M | $158.07M | $138.97M | $142.66M | $156.64M | $186.43M |